These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8234106)

  • 21. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
    Hirsch JL; Bensoussan JJ; Mosnier M; Lehert P
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naftidrofuryl in the treatment of subacute stroke.
    Capon A; Lehert P; Opsomer L
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S62-6. PubMed ID: 1369722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naftidrofuryl in the treatment of vascular dementia.
    Möller HJ; Hartmann A; Kessler C; Rainer M; Brown T; Gamand S; Lehert P
    Eur Arch Psychiatry Clin Neurosci; 2001 Dec; 251(6):247-54. PubMed ID: 11881837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous naftidrofuryl for critical limb ischaemia.
    Smith FB; Bradbury AW; Fowkes FG
    Cochrane Database Syst Rev; 2000; (2):CD002070. PubMed ID: 10796677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial.
    Emeriau JP; Lehert P; Mosnier M
    Clin Ther; 2000 Jul; 22(7):834-44. PubMed ID: 10945510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approach to treatment of recent stroke.
    Admani AK
    Br Med J; 1978 Dec; 2(6153):1678-9. PubMed ID: 367511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia].
    Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M
    G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomised controlled trial of hydroquinine in muscle cramps.
    Jansen PH; Veenhuizen KC; Wesseling AI; de Boo T; Verbeek AL
    Lancet; 1997 Feb; 349(9051):528-32. PubMed ID: 9048790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. I suffer from frequent leg cramps and I've heard that quinine can help. Should I consider taking it?
    Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):8. PubMed ID: 20572320
    [No Abstract]   [Full Text] [Related]  

  • 31. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study.
    Grossmann WM; Standl A; May U; van Laak HH; Hirche H
    Pharmacopsychiatry; 1990 Nov; 23(6):265-73. PubMed ID: 2284328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
    Goldsmith DR; Wellington K
    Drugs Aging; 2005; 22(11):967-77. PubMed ID: 16323973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of naftidrofuryl on transcutaneous oxygen tension during a treadmill test in patients with peripheral arterial occlusive disease.
    Mouren X; Caillard P; Bensoussan JJ; Massonneau M; Gamand S; Stevens WH
    Vasc Med; 1998; 3(1):9-14. PubMed ID: 9666526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naftidrofuryl for intermittent claudication: a double-blind controlled trial.
    Ruckley CV; Callam MJ; Ferrington CM; Prescott RJ
    Br Med J; 1978 Mar; 1(6113):622. PubMed ID: 343869
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.
    Barradell LB; Brogden RN
    Drugs Aging; 1996 Apr; 8(4):299-322. PubMed ID: 8920176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of naftidrofuryl ('Praxilene') on hepatic microsomal enzymes.
    Majumdar SK; Shaw GK; Thomson AD
    Pharmatherapeutica; 1980; 2(5):305-8. PubMed ID: 6107932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication.
    Rosas G; Cerdeyra C; Lucas MA; Parano JR; Villa JJ
    Angiology; 1981 May; 32(5):291-7. PubMed ID: 7235299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet aggregation after naftidrofuryl application in vitro and ex vivo.
    Kirsten R; Erdeg B; Moxter D; Hesse K; Breidert M; Nelson K
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):81-4. PubMed ID: 7757315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
    Kriessmann A; Neiss A
    Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.